Treatment for Macular Degeneration
- 0About this program
- 1Current treatments for wet AMD
- 2How are injections administered?
- 3Laser treatments
- 4New treatments
- 5Future treatment
- 6Research for wet AMD
- 7Research for dry AMD
- 8Stem cell therapy
- 9Gene therapy
- 10Research for dystrophies
- 11Can I take part in research?
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
Research for dry AMD
Researchers are looking at different ways to find a treatment for dry AMD as it is a complex disease, still not fully understood.
A popular approach is to look for drugs which will reduce the inflammation in the eye cells which causes damage and leads to sight loss.
Another approach is to try and keep the photoreceptors alive for longer. Both approaches would slow the progress of the disease.
Brimonidine, APL-2 and Zimura
These promising new drugs may lead to treatments for dry AMD.
Brimonidine would be an implant in the eye that gradually releases the drug.
APL-2 and Zimura would be eye injections. All are currently in Phase 3 clinical trials, which is the last stage of testing. If they show the drug is safe and effective, the companies will seek a licence to give it to patients.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.